{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:38:33Z","timestamp":1777055913603,"version":"3.51.4"},"reference-count":31,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch CRPS patient"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Objectives: Complex regional pain syndrome (CRPS) is a heterogeneous pain disorder with incompletely understood immunoinflammatory features. This study investigated whether autonomic receptor autoantibodies differentiate CRPS from other chronic pain conditions and healthy controls. Methods: We conducted a cross-sectional analysis of serum samples from patients referred with suspected CRPS. Patients were subsequently classified as having either CRPS or another chronic pain condition, based on the Budapest criteria. Healthy controls were included for comparison. Serum levels of autoantibodies targeting the muscarinic M2 receptor (M2R), \u03b21-adrenergic receptor (\u03b21AR), and the \u03b22-adrenergic receptor (\u03b22AR) were assessed using enzyme-linked immunosorbent assay. All analyses were performed blinded to group assignment. Results: Seventy participants were analyzed (CRPS = 22, other chronic pain = 25, healthy controls = 23). M2R autoantibody levels were higher in both CRPS and other chronic pain compared with healthy controls (mean difference [MD] = 0.37, 95%CI 0.22\u20130.51; and MD = 0.31 95%CI 0.19\u20130.44, respectively). \u03b22AR levels were higher in other chronic pain compared with healthy controls (MD = 0.29, 95%CI 0.04\u20130.54), whereas no significant difference was observed in CRPS (MD = 0.21 95%CI \u22120.01\u20130.42). No meaningful differences were observed between CRPS and other chronic pain for any receptor. \u03b21AR levels did not differ between groups. Seropositivity for any autoantibody was 55% in CRPS, 44% in other chronic pain, and 22% in healthy controls. Conclusions: Elevated autonomic receptor autoantibody levels were observed across chronic pain conditions but were not specific for CRPS.<\/jats:p>","DOI":"10.3390\/biomedicines14040945","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:00:32Z","timestamp":1776859232000},"page":"945","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autonomic Receptor Autoantibodies in Complex Regional Pain Syndrome and Other Chronic Pain Conditions: A Cross-Sectional Analysis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5435-9906","authenticated-orcid":false,"given":"Dani\u00ebl P. C.","family":"van der Spek","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Center for Pain Medicine, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e H.","family":"Hoffenkamp","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Center for Pain Medicine, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J. P. M.","family":"Huygen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Center for Pain Medicine, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna D.","family":"Bharwani","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Center for Pain Medicine, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-7063","authenticated-orcid":false,"given":"Niels","family":"Eijkelkamp","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"Dirckx","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Center for Pain Medicine, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11916-023-01124-3","article-title":"Complex Regional Pain Syndrome (CRPS) and the Value of Early Detection","volume":"27","author":"Harnik","year":"2023","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jpain.2014.01.500","article-title":"The outcome of complex regional pain syndrome type 1: A systematic review","volume":"15","author":"Bean","year":"2014","journal-title":"J. Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pain.2010.04.030","article-title":"Validation of proposed diagnostic criteria (the \u201cBudapest Criteria\u201d) for Complex Regional Pain Syndrome","volume":"150","author":"Harden","year":"2010","journal-title":"Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1097\/PR9.0000000000000624","article-title":"Complex regional pain syndrome-up-to-date","volume":"2","author":"Birklein","year":"2017","journal-title":"Pain Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40265-022-01685-4","article-title":"From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome","volume":"82","author":"Mangnus","year":"2022","journal-title":"Drugs"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/j.pain.0000000000002245","article-title":"The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria","volume":"162","author":"Goebel","year":"2021","journal-title":"Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e13413","DOI":"10.1111\/papr.13413","article-title":"10. Complex regional pain syndrome","volume":"25","author":"Dirckx","year":"2025","journal-title":"Pain Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/aas.12465","article-title":"Inflammation in cold complex regional pain syndrome","volume":"59","author":"Dirckx","year":"2015","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2147\/JPR.S423733","article-title":"The Role of Neuroinflammation in Complex Regional Pain Syndrome: A Comprehensive Review","volume":"16","author":"Wen","year":"2023","journal-title":"J. Pain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.pain.2011.06.012","article-title":"Autoimmunity against the beta2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome","volume":"152","author":"Kohr","year":"2011","journal-title":"Pain"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lopes, R., Santos, A., Gomes, T., Ribeiro, J., Rodrigues, I., Paiva, B., Nzwalo, I., Catamo, D., Baco, J., and Buque, H. (2025). An Integrative Review of Potential Diagnostic Biomarkers for Complex Regional Pain Syndrome. J. Clin. Med., 14.","DOI":"10.20944\/preprints202504.2314.v1"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pain.2009.03.009","article-title":"Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen","volume":"143","author":"Kohr","year":"2009","journal-title":"Pain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1212\/01.WNL.0000143066.58498.BA","article-title":"Autoimmune etiology of complex regional pain syndrome (M. Sudeck)","volume":"63","author":"Blaes","year":"2004","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"718201","DOI":"10.1155\/2015\/718201","article-title":"The prevalence of autoantibodies in complex regional pain syndrome type I","volume":"2015","author":"Dirckx","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.pain.2014.09.022","article-title":"Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors","volume":"155","author":"Dubuis","year":"2014","journal-title":"Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1097\/j.pain.0000000000002646","article-title":"Autoantibodies from patients with complex regional pain syndrome induce pro-inflammatory effects and functional disturbances on endothelial cells in vitro","volume":"163","author":"Dharmalingam","year":"2022","journal-title":"Pain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"504.e1","DOI":"10.1016\/j.ejpain.2010.10.005","article-title":"The passive transfer of immunoglobulin G serum antibodies from patients with longstanding Complex Regional Pain Syndrome","volume":"15","author":"Goebel","year":"2011","journal-title":"Eur. J. Pain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13067","DOI":"10.1073\/pnas.1820168116","article-title":"Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms","volume":"116","author":"Helyes","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1097\/j.pain.0000000000001662","article-title":"Autoantibodies produce pain in complex regional pain syndrome by sensitizing nociceptors","volume":"160","author":"Cuhadar","year":"2019","journal-title":"Pain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6259064","DOI":"10.1155\/2020\/6259064","article-title":"Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting","volume":"2020","author":"Bharwani","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"335","author":"Altman","year":"2007","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12020-014-0495-4","article-title":"Activating autoantibodies to the beta1\/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism","volume":"49","author":"Galloway","year":"2015","journal-title":"Endocrine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaut.2003.12.004","article-title":"Methods of choice for diagnostic antinuclear antibody (ANA) screening: Benefit of adding antigen-specific assays to immunofluorescence microscopy","volume":"22","author":"Dahle","year":"2004","journal-title":"J. Autoimmun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/j.pain.0000000000000927","article-title":"A prospective, multisite, international validation of the Complex Regional Pain Syndrome Severity Score","volume":"158","author":"Harden","year":"2017","journal-title":"Pain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103855","DOI":"10.1016\/j.autrev.2025.103855","article-title":"Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium","volume":"24","author":"Schimke","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Marques","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jcim.1c01056","article-title":"Classification Model for the Second Extracellular Loop of Class A GPCRs","volume":"62","author":"Nicoli","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tips.2020.11.013","article-title":"Autoantibodies as Endogenous Modulators of GPCR Signaling","volume":"42","author":"Skiba","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100056","DOI":"10.1016\/j.bbih.2020.100056","article-title":"Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders","volume":"4","author":"Halpert","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/pathophysiology29030033","article-title":"Autoimmune Autonomic Dysfunction Syndromes: Potential Involvement and Pathophysiology Related to Complex Regional Pain Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Silicone Breast Implant-Related Symptoms and Post-COVID Syndrome","volume":"29","author":"Mahroum","year":"2022","journal-title":"Pathophysiology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.bbih.2020.100107","article-title":"Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients\u2014A validation study in plasma and cerebrospinal fluid from two Swedish cohorts","volume":"7","author":"Bynke","year":"2020","journal-title":"Brain Behav. Immun. Health"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/945\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:46:55Z","timestamp":1777052815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["biomedicines14040945"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14040945","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}